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Abstract. Considering its long latency, prostate cancer (PCa) 
represents an ideal target for chemoprevention strategies. Green 
tea extract (GTE) has been proved to be one of the most prom-
ising natural substances capable of inhibiting PCa progression in 
animal models (transgenic adenocarcinoma of mouse prostate), 
as well as in humans. However, the cellular targets of the GTE 
action are mostly unknown. The main objective of this work 
was to investigate whether the endoplasmic reticulum (ER) 
and the Golgi apparatus (GA), known to be actively involved 
in sensing stress stimuli and initiating and propagating cell 
death signalling, may represent the subcellular targets of GTE 
action. To this end, 42 TRAMP mice were divided into four 
experimental groups: groups II and IV, received GTE in tap 
water (0.3 g/100 ml solution) starting at 8 weeks of age and up 
to the time of sacrifice. Groups I and III were respective age-
matched water-fed controls. The animals were sacrificed after 
4 weeks (groups I and II) or 40 weeks of treatment (groups II 
and IV). We also treated TRAMP-C2 cells with GTE (20 µg/ml 
for 7 days) to check the expression profile of clusterin (CLU), 
a protein involved in prostate tumourigenesis, extensively 
processed through ER-GA before being secreted through the 
plasma membrane. In vivo we found that chronic administra-
tion of GTE in TRAMP mice results in collapse of ER and GA 
in prostate epithelial cells. Consistently, in vitro we found that 
the mature, fully processed form of CLU, sCLU, is strongly 
reduced by GTE treatment in TRAMP-C2 cells. Taking into 
account the sCLU biogenesis dependence on the ER-GA integ-
rity and the proposed anti-apoptotic role of sCLU, the possibility 
for GTE to counteract PCa progression by interfering with 
sCLU biogenesis is suggested.
Introduction
Genetically engineered animal models have emerged as 
fundamental tools to study many pathological conditions, 
including cancer, and to find new therapeutic strategies. The 
transgenic adenocarcinoma of mouse prostate (TRAMP) is an 
experimental model for prostate cancer (PCa), which closely 
mimics the pathogenesis of the human disease. TRAMP 
mice express SV40 T/t antigen under the control of the 
prostate-specific minimal rat probasin promoter (1). In fact, it 
represents a genetically defined paradigm in which to inves-
tigate the stochastic molecular progression of prostate cancer 
from prostatic intraepithelial neoplasia (PIN), through well 
differentiated localized disease, to invasive and metastatic 
androgen-independent cancer (1,2). Many detailed anatomical 
and histological studies of TRAMP mouse prostate have been 
reported since this model was created by Greenberg in 1995 
(1-7) showing quantitative analysis of the incidence and distri-
bution of pathological lesions as a function of aging. 
Numerous studies, by us and others, indicate that PCa 
development in TRAMP mice as well as in humans, is inhibited 
or delayed by green tea extracts (GTE) administration (8-12); 
to our knowledge, however, a systematic description of the 
morphological changes of the prostate epithelium associated 
with GTE consumption is still missing.
Here we used the transmission electron microscopy (TEM) 
analysis to explore possible structural changes that might 
occur at the level of the intimate morphology of the secretory 
epithelial components in the prostatic acinar adenomeres of 
TRAMP mice. The study was conducted during the develop-
ment of PCa, either as a function of aging and following the 
chemopreventive GTE treatment.
Very recent convincing evidence indicates that the secre-
tory pathway, i.e. the endoplasmic reticulum (ER) and the 
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Golgi apparatus (GA), can be actively involved in sensing stress 
stimuli and even initiating and propagating cell death signaling 
(13), which may represent a new interesting drug target for 
possible therapeutic interventions. Based on this consideration, 
we focused our microscopic observation mainly on the secre-
tory pathway, assuming that GTE might affect the activity of 
the ER-GA, thus deregulating protein trafficking through the 
cytoplasm. 
In order to explore this hypothesis with a multidisciplinary 
approach, we paralleled our in vivo experiments with in vitro 
ones using TRAMP-C2 cells a syngeneic prostate cancer cell 
line established from a heterogeneous tumor of the TRAMP 
model (14). In these cells we studied the effect of chronic 
GTE administration on the maturation of proteins processed 
through the secretory pathway. More precisely we character-
ized, by Western blot analysis, the pattern of expression of 
clusterin (CLU), a paradigmatic secreted protein, involved 
in PCa development (15,16), extensively processed in the 
ER-GA after translation of the primary transcript (17,18). CLU 
processing, includes heavy glycosylation of a precursor protein 
(pCLU) and cleavage to an α-β dimer before being secreted 
through the plasma membrane (sCLU) (17). It is well known 
that CLU post-translational processing is deeply affected by 
many conditions involving ER-GA stress (19,20). Although 
CLU-specific role in tumourigenesis is still a matter of debate 
(15,16,21), there is common consent on the cyto-protective, 
pro-survival role of sCLU (22). Thus, the present paper repre-
sents, to our knowledge, the first morphological ultrastructural 
study of the TRAMP mouse prostatic secretory cells as a func-
tion of disease progression and following GTE administration. 
The experimental data reported here suggest that in TRAMP 
mouse prostatic secretory cells a mechanism may exist through 
which GTE affects the condensing and secretory activities of 
the ER-GA. This in turn would affect CLU processing causing 
a reduction of sCLU production, thus blocking the cyto-protec-
tive action of the protein on prostate cells. 
Materials and methods
Animals. TRAMP mice, heterozygous for the PB-Tag trans-
gene were obtained as (TRAMP x C57BL/6)F1 or F2 offspring 
and maintained in a C57BL/6 background. The animals were 
housed according with protocols approved by the institutional 
laboratory animal care and use committee of Italy. Tail tips 
from all male offspring were genotyped by polymerase chain 
reaction to identify mice carrying the transgene as previously 
described (1). 
For the present research we used 42 mice assigned to 4 
experimental groups identified with roman numerals (Table I). 
The animals had access to laboratory chow and water ad libitum. 
Animals belonging to the groups II and IV, received GTE in tap 
water (0.3 g/100 ml solution) as previously made (10), starting at 
the age of 8 weeks until the sacrifice. Animals belonging to the 
groups I and III represent their respective age-matched water-
fed controls. The 0.3% GTE solution was freshly prepared and 
replaced every Monday, Wednesday and Friday. GTE treatment 
did not affect either the animal weight, or the SV40 tag expres-
sion. At established time (12 and 48 weeks of age) the animals 
were sacrificed, according to the rules of the Ethics Committee, 
under ether anaesthesia.
Green tea extract. TRAMP mice and TRAMP-C2 prostate 
cancer cells were treated with Polyphenon-E®, a standard-
ized green tea polyphenols extract produced by Mitsui Norin, 
Shizuoka, Japan and kindly provided by Polyphenon Pharma, 
New York, USA. The mixture, hereafter referred as GTE, 
contains (-)-epigallocatechin-3-gallate (54.8%), (-)-epigallocat-
echin (9.2%), (-)-epicatechin (10.8%), (-)-epicatechin-3-gallate 
(6.5%), (-)-gallocatechin-3-gallate (4.0%), (-)-catechin-3-gal-
late (0.2%), gallactocatechin (0.2%), catechins (1.1%) and is 
virtually caffeine free (0.7%). 
Transmission electron microscopy analysis. Immediately after 
excision, prostate samples of ~2-3 mm of diameter were fixed 
in 1% osmium tetroxide solution buffered with sodium veronal 
buffer (pH 7.4) for 1 h. After being washed in Tyrode's solu-
tion, specimens were dehydrated in a graded series of acetone 
solutions and embedded in Durcupan (Fluka Chemie, Buchs, 
Switzerland).
Semithin sections (1 µm thick) were stained with 0.5% 
toluidine blue, whereas ultrathin sections were stained 
with uranyl acetate and lead citrate (23) and observed by 
TEM (Philips 300, Philips, Eindhoven, The Netherlands). 
Histological and cytological controls excluded signs of distress 
and/or degenerative phenomena of the samples.
Cells, growth conditions and treatments. Murine tumouri-
genic prostate cancer TRAMP-C2 cells were purchased from 
the American Tissue Culture Collection and maintained 
in DMEM high glucose medium (Gibco, Grand Island, NY) 
containing 5% FBS (Lonza Ltd., Basel, CH), 5% Nu-serum 
(Gibco), 1% L-glutamine (Sigma Chemical Inc., St. Louis, MO), 
0.005 mg/ml bovine Insulin (Sigma Chemical Inc.) and 10 nM 
dihydrotestosterone (Sigma Chemical Inc.). Cells (2,5x105) 
were seeded in T75 flasks and cultured at 37˚C in a 5% CO2 
atmosphere.
Twenty-four hours after seeding, cells were treated with 
20 µg/ml of GTE. This represents a sub-lethal dose able to 
reduce drastically cell proliferation. Cell medium was replaced 
every 48 h, and at each medium change GTE was added. Treated 
cells and their respective culture medium were collected after 
7 days of treatment. Untreated cells, used as control, were 
harvested 48 h after seeding at a confluence comparable with 
that of treated cells.
Western blot analysis. Treated or untreated cells were washed 
twice with ice-cold PBS and scraped into ice-cold lysis buffer 
[50 mmol/l Tris-HCl (pH 8.0), 1% Triton X-100, 150 mmol 
NaCl] with protease inhibitors (Roche Diagnostic, Mannheim, 
Table I. Description of the experimental groups.
Group Animals no. GTE treatment Age of sacrifice
name  (time) (weeks)
Group I   9 No 12
Group II   9 Yes (4 weeks) 12
Group III 12 No 48
Group IV 12 Yes (40 weeks) 48
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Germany) at the indicated times. Total protein lysates were 
resolved by SDS-PAGE, under reducing condition, (50 µg 
protein/lane), and electrophoretically transferred to PVDF 
membranes (Millipore Corporation, Billerica, MA). Transfer 
efficiency on the membranes was routinely monitored by 0.1% 
Red Ponceau S (Sigma Chemical). Membranes were probed 
with the following antibodies: anti-mouse β-clusterin (dilu-
tion 1:1000) from Santa Cruz Biotechnology (Santa Cruz, 
CA) and anti-human β-actin (dilution 1:2000) from Millipore 
Chemicon International (Temecula, CA). 
Results
Group I: 12-week-old water-fed TRAMP mice. The epithelium 
of the dorso-lateral lobes of 12-week-old TRAMP mouse 
prostate exhibits PIN lesions. Many small and dense granules 
appear uniformly dispersed within a colloid-like secretion. 
Nuclei located in the medio-basal cytoplasm contain a central 
nucleolus and are surrounded by distinct dense secretion gran-
ules (Fig. 1A). 
In the supranuclear cytoplasm many secretory vacuoles, 
electrondense secretory granules and a well-developed Golgi 
apparatus (GA), composed by curvilinear clusters of cisternae 
(g), are detected by TEM analysis (Fig. 1B, C and D). Many 
vacuoles located in the area between the GA and apical plasma 
membrane contain floccular material (v) with occasional dense 
core. Some vacuoles, characterized by a middle electron-dense 
secretion, and some secretory granules, frequently adhere and 
fuse to the luminal plasma membrane undergoing exocytosis 
(Fig. 1B, arrow). Dense bodies, similar to lysosomes, appear 
more numerous in the basal cytoplasm than in the Golgi area. 
It is worth noting that mostly tubular ER (r) is enlarged and, 
occasionally, displays a concentric arrangement (Fig. 1B). By 
histological and ultrastructural analyses the epithelial cells are 
characterized by a marked secretory activity. 
Group II: 12-week-old TRAMP mice treated with GTE. The 
histological (Fig. 2A) and ultrastructural (Fig. 2B, C, D and 
E) features of the secretory prostatic epithelial cells of the 
12-week-old TRAMP mice, after 4 weeks of GTE administra-
tion, are similar to those observed in the age-paired TRAMP 
mouse control group. In a typical picture of the secretory 
cells, a mature GA (g) exhibiting presecretory granules in the 
trans-face (Fig. 2B and C) is surmounted by many secretory 
vacuoles (v) with finely granular or amorphous material and 
small electron-dense granules. In the basal and perinuclear 
cytoplasm a tubular ER (Fig. 2C, r), lipofuscine-like dense 
bodies (arrowheads) and some phagosomes (ly) are also 
present (Fig. 2D and E).
Group III: 48-week-old water-fed TRAMP mice. The secretory 
epithelium of 48-week-old TRAMP mice exhibited nuclear 
stratification, micropapillar projections, scarce hyperchro-
matic and elongated nuclei (Fig. 3A). The GA (g, circles) in the 
epithelium lining the acini is not as well developed (Figs. 3B, D 
and E) as in the younger animals (group I); it is characterized 
by smaller expanded cisternae and vesicles. In the apical area 
of the cells, the cytoplasm, displaying a rather compact matrix, 
contains some secretory granules, electrondense vacuoles 
undergoing exocytosis (Fig. 3C, arrow) and secretory granules 
with electrondense content (Fig. 3D, arrowheads). Many dense 
bodies and secondary lysosomes (ly) can be seen in the basal 
cytoplasm (Fig. 3E). In comparison to the animals belonging 
to the group I we observed fewer interdigitations between the 
membranes of adjacent epithelial cells. 
Group IV: 48-week-old TRAMP mice treated with GTE. Mice 
belonging to this experimental group exhibit only early signs 
of transformation. Most of the secretory acinar cells are char-
acterized by a compressed cubical epithelium that occasionally 
forms modest folds, protruding in a very dilated acinar cavity, 
full of a high-dense granular material (Fig. 4A). Unlike the 
age-paired water-fed TRAMP mice (group III), many secre-
tory cells present signs of apoptosis, but very few of them 
exhibit signs of mitosis. 
As the most relevant ultrastructural finding, the cytoplasm, 
characterized by a structureless matrix of middle density, pres-
ents both the ER and GA strongly reduced in volume. In the 
Figure 1. Twelve-week-old water-fed TRAMP mice: group I. The cuboidal-cylindrical epithelium (A, magnification x60, toluidine blue stain) protrudes often 
into small folds (PIN lesions) and rests on a thin basal lamina, externally lined by more smooth fibromuscular layers (arrow). TEM analysis (B, C and D, 
magnification x5670, x6750 and x4670, respectively) shows a marked synthetic activity denoted by well developed GA (g), concentric disposed ER tubules (r), 
numerous condensing vacuoles (v) and secretory granules with electrondense content. →, exocytotic vacuoles; ►, tight and gap junctions.
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Figure 2. Twelve-week-old TRAMP mice treated with GTE: group II. Toluidine blue stain of the secretory cylindrical epithelium of the acinar adenomeres 
(A, magnification x72). TEM analysis (B and C, magnification x3500 and x6670, respectively) shows large GA (g), well developed rough ER (r) and numerous 
condensing vacuoles and secretory granules (v). Lipofuscine-like dense bodies (arrowheads) and some phagosomes (ly) were also distributed in the basal 
cytoplasm (D and E, magnification x6670 and x4670, respectively). Neuroendocrine cells, positive to the 5-hydroxytryptamine reaction (e), smooth muscle 
fibrocells (f). ►, tight and gap junction.
Figure 3. Forty-eight-week-old untreated TRAMP mice: group III. Toluidine blue stain of the secretory cylindrical epithelium (A) (magnification x200) show 
acinar adenomeres in a differentiated adenocarcinoma stage, few hyperchromatic nuclei and an increased number of apoptotic cells. TEM analysis (B, C 
and D, magnification x5000, x7000 and x7000, respectively) shows a large GA (g, circles), enlarged ER tubules (r) a low number of condensing vacuoles and 
granules, with dense content in the apical cytoplasm (arrowhead). Arrow, exocytotic vacuoles. Secondary lysosomes (ly) and dense bodies are detected in the 
basal cytoplasm. Endocrine cells (positive to the 5-hydroxytryptamine reaction) and basal cells are very scarce (E, magnification x7500).
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supranuclear area, the ER is constituted by very scant, flattened 
single tubules, lined by ribosomes. The GA (g, circles) consists in 
small clustered cisternae and in few secretory vesicles (Fig. 4B 
and C). Likewise, in the apical cytoplasm, the condensing 
secretory vacuoles and the electron-dense secretory granules 
are scarce. Interestingly, we detected also many lysosomes 
(ly), fagolysosomes, fagosomes (Fig. 4D), big masses consti-
tuted of heterogeneous electrondense material, myelinic 
figures (Fig. 4E, arrows) and large cytoplasmic vacuoles, 
undergoing catabolic processes. The plasma membranes of 
the secretory epithelium also exhibit conspicuous lateral 
interdigitations with adjacent cells. Desmosomes and special-
ized junctional complexes are present in the apical cytoplasm 
(Fig. 4D and E). 
The activity of ER-GA in TRAMP-C2 cells treated with GTE 
is impaired. To obtain functional proof that GTE administra-
tion causes a dysfunction of the ER-GA activity in the prostate 
epithelial cells, we monitored CLU expression in TRAMP-C2 
cells, chronically treated with a sub-lethal concentration of 
GTE (20 µg/ml for 7 days). Under physiological conditions, the 
CLU precursor (an uncleaved and unglycosylated peptide of 
~60 kDa) is modified (mainly by glycosylation) in the ER and 
Figure 4. Forty-eight-week-old TRAMP mice treated with GTE: group IV. The secretory cuboidal-cylindrical epithelium (A, magnification x220) forms small 
folds and rests on a basal membrane lined by more smooth fibromuscular cells. TEM analysis (B and C, magnification x9000 and x11250, respectively) shows 
a poorly developed GA (g, circles) and a tubular and poorly extended ER (r) and scarse condensing vacuoles and secretory vescicles. Numerous dense 
bodies (c), phagolysosomes (ly) large masses containing heterogeneous material and myelinic figures are also shown (arrows D and E, magnification x4560). 
►,= desmosomes, tight and gap junctions. 
Figure 5. Clusterin biogenesis is modified in TRAMP-C2 cells treated with 
GTE. TRAMP-C2 cells were seeded and grown under standard conditions 
for 24 h. Then cells were exposed to GTE (20 µg/µl) and harvested after 7 days 
of treatment. Cell culture medium were also collected. β-actin expression is 
provided to show equal loading of the samples. pCLU, precursor CLU 60 kDa; 
psCLU, presecretory CLU 64 kDa; sCLU, secreted CLU 40 kDa; C, control 
cells (untreated).
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proteolytically cleaved in the GA, to generate discrete α and β 
chains (40 kDa each), prior to secretion.
As shown by WB analysis (Fig. 5), the pattern of expres-
sion of CLU in untreated TRAMP-C2 cells is characterized 
by three bands: the unmodified CLU precursor (pCLU, 
60-kDa band), the CLU presecretory, uncleaved and partially 
glycosylated peptide (psCLU, 64-kDa band) and the mature 
form of CLU fully glycosylated (sCLU, 40-kDa band under 
reducing conditions). After 7 days of GTE treatment, both 
partially (psCLU, 64 kDa) and full processed (sCLU, 40 kDa) 
intracellular forms are strongly reduced, while the unmodi-
fied precursor (pCLU, 60 kDa) remains unmodified under the 
same experimental conditions. 
We checked also for CLU content in the culture medium of 
control and treated cells. Consistenly with the results obtained 
with cellular protein lysates, we found that sCLU is drasti-
cally reduced in the medium of treated cells with respect to 
untreated ones. 
Discussion
The basic structural definition of the TRAMP mouse prostate 
was previously reported by Kaplan-Lefko et al (2) and Gingrich 
et al (5) by means of optical microscopy, at different time inter-
vals during PCa development. More recently, one of us showed 
the transendothelial passage of invasive tumour prostate cells 
from the extravasal matrix into the lymphatic vessel (24) in the 
same animal model. 
In the present study, we extend the current knowledge of 
TRAMP mouse prostate morphology performing a detailed 
ultrastructural study of the secretory epithelial components of 
the prostatic acinar adenomeres in TRAMP mice, at 12 and 
48 weeks of age. We paralleled the microscopic observation in 
age-matched TRAMP mice receiving GTE in tap water. Our 
present study design allowed us to gain insights into possible 
early ultrastructural alterations that might occur within the 
prostate gland in connection with the chemopreventive action 
of GTE.
We observed that the acinar adenomeres of 12-week-old 
TRAMP mice (group I) are characterized by scant preneo-
plastic and neoplastic lesions. Histological and ultrastructural 
analyses reveal a high secretory activity, accompanied by a 
colloid-like acinar secretion, which is uniformly enriched by 
small dense granules. 
GTE administration to 12-week-old TRAMP mice (group II) 
during the last 4 weeks before sacrifice does not cause signifi-
cant changes within the acinar cell components, as compared 
to age-matched control mice (group I). Forty-eight-week-old 
TRAMP mice (group III), exhibit a mild secretory activity, 
accompanied by a highly electrondense acinar cavity secre-
tion, characterized by a strong affinity for haematoxylin. The 
different features of the prostatic secretion between 12- and 
48-week-old mice may result from the reduced secretion 
activity, either due to animal aging or thickening of the secre-
tory material caused by its slowed delivery through the tubular 
branching. 
The epithelial acinar cells of TRAMP mice treated with 
GTE for 40 weeks before sacrifice (group IV), show significant 
modifications with respect to their age-matched untreated group 
(group III). Mice belonging to group IV exhibit only early patho-
logical lesions with respect to time-matched untreated animals, 
possibly due to the chemopreventive action of GTE treatment.
We found a bold reduction of the organelles committed to 
the synthetic and secretory activities, ER and GA; consistently, 
the secretion condensing vacuoles and the secretory vesicles 
are very scarce. Many lysosomes and secondary lysosomes 
(fagolysosomes/auto-phagolysosomes) are also evident, 
together with large masses of heterogeneous electron-dense 
material and myelinic figures. The existence of large vacuoles 
containing cytoplasm undergoing degradation is also note-
worthy. The overall picture strengthens the assumption that 
GTE administration can inhibit the condensing and secretory 
activities of the ER-GA. 
Differently to that observed in group III, the plasma 
membranes of the secretory epithelium exhibit conspicuous 
lateral interdigitations with adjacent cells, desmosomes and 
specialized junctional complexes. It is well know that cell-cell 
junctional complexes play a crucial role in the establishment 
and maintenance of cell polarity. Reduced cell-cell interactions 
result in destruction of overall tissue architecture, a morpho-
logical hallmark of both early (loss of cell polarity and growth 
control) and late (invasion and metastasis) stages of tumour 
progression (25). 
The morphological observation of a reduced activity of 
the ER-GA in the prostatic acinar cells is consistent with our 
in vitro findings of an altered CLU biogenesis in TRAMP-C2 
cells, after treatment with GTE. The main product of the 
CLU gene is a mature secreted, glycosylated protein (sCLU), 
obtained through post-translational modification in the ER-GA 
of a CLU precursor protein (pCLU). In the present study we 
monitored pCLU and sCLU expression in TRAMP-C2 cells 
upon chronic administration of a sub-lethal dose of GTE to 
culture medium. The treatment quickly reduces sCLU expres-
sion, both in the cells and in the medium, while pCLU remains 
at the same level as in untreated cells. These experimental 
results are compatible with a marked slowdown of the biosyn-
thetic and condensing processes of the ER-GA, that alters the 
processing velocity of pCLU and presents sCLU as a good 
marker for monitoring in vitro ER-GA functional status.
O'Sullivan et al reported that CLU processing through 
the ER-GA is drastically modified in MCF-7 cells, following 
treatment with Brefeldin A, a drug which induces stress of the 
ER via inhibition of ADP ribosylation factor (19). By using 
several complementary approaches Nizard et al, provided 
experimental evidence that partially processed CLU, under 
ER stressing conditions, can evade the secretion pathway 
being retrotraslocated from the ER-GA to the cytosol (20). 
Our in vivo data show that GTE administration can drastically 
reduce the activity of the secretory pathway, possibly causing 
an imbalance of the protein trafficking. This phenomena would 
engulf the epithelial prostate cell cytoplasm with dense mate-
rial. Recently, Wlodkowick et al have indicated that alterations 
of the ER-GA trafficking homeostasis is a signal for activation 
of digestion of exceeding endogenous material in the cell and 
also initiatiating and propagating cell death signaling (13).
It is rationale to speculate that the inhibition of the 
secretory activity in the TRAMP mice prostate after GTE 
administration might affect CLU processing, preventing its 
extensive glycosylation, cleavage and extracellular secretion, 
similarly to that in vitro. The consequent change in the pCLU/
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sCLU ratio might take part in the processes leading GTE to 
counteract PCa progression (19,26-28). The above hypothesis 
is currently under investigation in our laboratory. 
Acknowledgments
We thank Polyphenon Pharma, New York, USA for supplying 
Polyphenon E and Mr. Davide Dallatana, Section of Human 
Anatomy, University of Parma, for collaboration in drawing 
up the iconographic material. Funding information: FIL 2006-
2008, University of Parma, Italy; AICR (UK) grant no. 06-711.
References
  1. Greenberg NM, DeMayo F, Finegold MJ, et al: Prostate cancer 
in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439-3443, 
1995.
  2. Kaplan-Lefko PJ, Chen TM, Ittmann MM, et al: Pathobiology of 
autochthonous prostate cancer in a pre-clinical transgenic mouse 
model. Prostate 55: 219-237, 2003.
  3. Yeh IT, Reddick RL and Kumar AP: Malignancy arising in 
seminal vesicles in the transgenic adenocarcinoma of mouse 
prostate (TRAMP) model. Prostate 69: 755-760, 2009.
  4. Tani Y, Suttie A, Flake GP, Nyska A and Maronpot RR: 
Epithelial-stromal tumor of the seminal vesicles in the transgenic 
adenocarcinoma mouse prostate model. Vet Pathol 42: 306-314, 
2005.
  5. Gingrich JR, Barrios RJ, Foster BA and Greenberg NM: Patho 
logic progression of autochthonous prostate cancer in the TRAMP 
model. Prostate Cancer Prostatic Dis 2: 70-75, 1999.
  6. Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ 
and Greenberg NM: Androgen-independent prostate cancer 
progression in the TRAMP model. Cancer Res 57: 4687-4691, 
1997.
  7. Gingrich JR and Greenberg NM: A transgenic mouse prostate 
cancer model. Toxicol Pathol 24: 502-504, 1996.
  8. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G and 
Corti A: Chemoprevention of human prostate cancer by oral 
administration of green tea catechins in volunteers with high-
grade prostate intraepithelial neoplasia: a preliminary report from 
a one-year proof-of-principle study. Cancer Res 66: 1234-1240, 
2006.
  9. Gupta S and Mukhtar H: Green tea and prostate cancer. Urol Clin 
North Am 29: 49-57, 2002.
10. Caporali A, Davalli P, Astancolle S, et al: The chemopreventive 
action of catechins in the TRAMP mouse model of prostate 
carcinogenesis is accompanied by clusterin over-expression. 
Carcinogenesis 25: 2217-2224, 2004.
11. Bettuzzi S, Rizzi F and Belloni L: Clinical relevance of the 
inhibitory effect of green tea catechins (GtCs) on prostate cancer 
progression in combination with molecular profiling of catechin-
resistant tumors: an integrated view. Pol J Vet Sci 10: 57-60, 2007.
12. Adhami VM, Siddiqui IA, Sarfaraz S, et al: Effective prostate 
cancer chemopreventive intervention with green tea polyphenols 
in the TRAMP model depends on the stage of the disease. Clin 
Cancer Res 15: 1947-1953, 2009.
13. Wlodkowic D, Skommer J, McGuinness D, Hillier C and 
Darzynkiewicz Z: ER-Golgi network - a future target for anti-
cancer therapy. Leuk Res 33: 1440-1447, 2009.
14. Foster BA, Gingrich JR, Kwon ED, Madias C and Greenberg NM: 
Characterization of prostatic epithelial cell lines derived from 
transgenic adenocarcinoma of the mouse prostate (TRAMP) 
model. Cancer Res 57: 3325-3330, 1997.
15. Rizzi F and Bettuzzi S: The clusterin paradigm in prostate and 
breast carcinogenesis. Endocr Relat Cancer 17: R1-R17, 2010.
16. Shannan B, Seifert M, Leskov K, et al: Challenge and promise: 
roles for clusterin in pathogenesis, progression and therapy of 
cancer. Cell Death Differ 13: 12-19, 2006.
17. Burkey BF, deSilva HV and Harmony JA: Intracellular processing 
of apolipoprotein J precursor to the mature heterodimer. J Lipid 
Res 32: 1039-1048, 1991.
18. French LE, Chonn A, Ducrest D, et al: Murine clusterin: 
molecular cloning and mRNA localization of a gene associated 
with epithelial differentiation processes during embryogenesis. J 
Cell Biol 122: 1119-1130, 1993.
19. O’Sullivan J, Whyte L, Drake J and Tenniswood M: Alterations 
in the post-translational modification and intracellular trafficking 
of clusterin in MCF-7 cells during apoptosis. Cell Death Differ 
10: 914-927, 2003.
20. Nizard P, Tetley S, Le Drean Y, et al: Stress-induced retrotrans-
location of clusterin/ApoJ into the cytosol. Traffic 8: 554-565, 
2007.
21. Trougakos IP, Djeu JY, Gonos ES and Boothman DA: Advances 
and challenges in basic and translational research on clusterin. 
Cancer Res 69: 403-406, 2009.
22. Pucci S and Bettuzzi S: Chapter 3: The shifting balance between 
CLU forms during tumor progression. Adv Cancer Res 104: 
25-32, 2009.
23. Reynolds ES: The use of lead citrate at high pH as an electron-
opaque stain in electron microscopy. J Cell Biol 17: 208-212, 
1963.
24. Azzali G: Tumor cell transendothelial passage in the absorbing 
lymphatic vessel of transgenic adenocarcinoma mouse prostate. 
Am J Pathol 170: 334-346, 2007.
25. Mareel M and Leroy A: Clinical, cellular, and molecular aspects 
of cancer invasion. Physiol Rev 83: 337-376, 2003.
26. Moretti RM, Marelli MM, Mai S, et al: Clusterin isoforms 
differentially affect growth and motility of prostate cells: possible 
implications in prostate tumorigenesis. Cancer Res 67: 10325-10333, 
2007.
27. Caccamo AE, Scaltriti M, Caporali A, et al: Nuclear transloca-
tion of a clusterin isoform is associated with induction of anoikis 
in SV40-immortalized human prostate epithelial cells. Ann NY 
Acad Sci 1010: 514-519, 2003.
28. Scaltriti M, Santamaria A, Paciucci R and Bettuzzi S: Intra-
cellular clusterin induces G2-M phase arrest and cell death in 
PC-3 prostate cancer cells. Cancer Res 64: 6174-6182, 2004.
